(资料图片仅供参考)

CFi.CN讯：海正药业（股票代码：600267）公布浙江海正药业股份有限公司2025年年度报告摘要。

2025年2024年本年比上年增减(%)2023年调整后 调整前调整后调整前总资产15,051,572,285.7615,972,478,068.0015,972,478,068.00-5.7717,613,281,702.7217,613,281,702.72归属于上市公司股东的净资产8,607,245,942.928,341,353,163.168,341,353,163.163.198,101,974,562.678,101,974,562.67营业收入10,549,640,956.8810,340,247,008.479,786,848,052.592.0310,052,577,933.7010,373,071,956.92利润总额815,376,113.02718,072,071.49718,072,071.4913.55-82,866,731.58-82,866,731.58归属于上市公司股东的净利润540,707,781.22601,182,827.25601,182,827.25-10.06-93,171,306.60-93,171,306.60归属于上市公司股东的扣除非经常性损益的净利润585,676,238.11430,305,723.33422,556,636.6236.11-106,201,819.87-100,015,816.10经营活动产生的现金流量净额2,031,676,015.422,184,093,536.552,114,532,552.48-6.981,456,637,142.571,502,669,446.74加权平均净资产收益率（%）6.417.437.43减少1.02个百分点-1.15-1.15基本每股收益（元／股）0.460.520.52-11.54-0.08-0.08稀释每股收益（元／股）0.460.520.52-11.54-0.08-0.08